SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-025599
Filing Date
2022-09-28
Accepted
2022-09-28 09:37:52
Documents
15
Period of Report
2022-09-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20220926.htm   iXBRL 8-K 42989
2 EX-99.1 a5825730_releasexpreview.htm EX-99.1 13027
6 a5825730_releasexpreview001.jpg GRAPHIC 403727
7 a5825730_releasexpreview002.jpg GRAPHIC 235131
  Complete submission text file 0001628280-22-025599.txt   1083881

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20220926.xsd EX-101.SCH 1893
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20220926_lab.xml EX-101.LAB 24831
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20220926_pre.xml EX-101.PRE 13037
9 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20220926_htm.xml XML 11254
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 221272994
SIC: 2834 Pharmaceutical Preparations